Role of the family in Treatment Decision-Making process for Omani women diagnosed with breast cancer

Abdulrahim Al-Bahri, Mansoor AL-Mandhari, Zahid Al-Mandhari, Mohammed Al-Azri*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

9 Citations (Scopus)


Objective: There is limited number of studies from Arabic countries on the participation of family members in Treatment decision-making (TDM) process. The aim of this study is to evaluate the role of family members in the TDM process among adult Omani women diagnosed with breast cancer. Methods: A cross-sectional study has been conducted with women diagnosed with breast cancer and their nominated family members. Results: A total of 79 patients and their nominated family members participated. The family members who were most engaged in the TDM were more likely to be young, male, employed and first-degree relative. The following characteristics of patients associated with more family-controlled the TDM: being older (crude odds ratio [OR] = 7.71; 95% confidence interval [CI]: 2.28–22.20), no formal education (OR = 0.18; 95% CI: 0.54) and diagnosed at stage IV (OR = 6.55; 95% CI: 1.89–22.65). The family members who dominate communication with the oncologists were more likely to control the TDM (OR = 6.03; 95% CI: 1.78–20.42). Conclusion: Several factors influence the TDM process including age, gender, employments status, educational level and capability of communication. Practice implications: The TDM process is heavily involves family members. This should be taking in consideration by oncologists during counselling in order to reach the best treatment.

Original languageEnglish
JournalPatient Education and Counseling
Publication statusAccepted/In press - Jan 1 2018


  • Breast
  • Cancer
  • Family members
  • Oman
  • Treatment decision-making
  • Women

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Role of the family in Treatment Decision-Making process for Omani women diagnosed with breast cancer'. Together they form a unique fingerprint.

Cite this